XLRI’s XCITE Opens Applications for Its First Rural Business Incubation Cohort

Jamshedpur (Jharkhand) [India], July 15: XCITE (XLRI Council for Innovation, Technology & Entrepreneurship), the Rural Business Incubator established at XLRI – Xavier School of Management with the support of NABARD, has announced the launch of applications for its first incubation cohort, inviting aspiring entrepreneurs from across 12 Eastern and North-Eastern states of India to build sustainable, high-impact rural enterprises.

The incubation programme is open to entrepreneurs from Jharkhand, Bihar, Odisha, West Bengal, Sikkim, Assam, Arunachal Pradesh, Manipur, Meghalaya, Mizoram, Nagaland, and Tripura. XCITE seeks to identify and nurture innovative ventures that address rural challenges while creating sustainable livelihoods and contributing to inclusive economic growth.

The incubator places special emphasis on women-led and tribal-led enterprises, as well as ventures operating in sectors such as agriculture, off-farm livelihoods, Non-Timber Forest Produce (NTFP), handicrafts, rural services, sustainability, green energy, circular economy, and other rural livelihood domains. The programme aims to support enterprises that are market-driven, scalable, and capable of generating long-term social and economic impact within rural communities.

Selected entrepreneurs will participate in a six-month hybrid incubation programme, comprising virtual mentoring sessions and immersive on-campus bootcamps at XLRI, Jamshedpur. Participants will receive grant support of up to ₹5 lakh, along with structured mentorship from domain experts, business model development support, market access guidance, investor and ecosystem linkages, peer learning opportunities, and access to the extensive networks of XLRI and NABARD.

Speaking on the launch, Mr. Ravish Vasan, CEO, XCITE, said:

“XCITE aims to nurture enterprises that combine commercial viability with social impact, enabling rural communities to become active participants in India’s growth story.”

Applications for the inaugural cohort are open until 25th July 2026.

Entrepreneurs may submit their applications online at:
https://xcite.accubate.app/ext/form/23776/1/apply

For further information, interested entrepreneurs and ecosystem partners may connect with XCITE, XLRI – Xavier School of Management.

For more details:
https://xlri.ac.in/xcite

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Education Entertainment Indian Universities Global Rankings Parul University QS Rankings 2027 Parul University Ranking QS World University Rankings Asia 2027 Southern Asia University Rankings

Parul University Moves up in QS World University Rankings: Asia 2027 with a Rank in the 791-800; and Secures 239th Position in Southern Asia

Vadodara (Gujarat) [India], November 6: Parul University in Gujarat has moved into the 791-800 band in the QS World University Rankings: Asia 2027. Last year, in the 2026 edition, it sat in the 1001-1100 band. The University has also been ranked 239th in the QS World University Rankings: Southern Asia 2027, marking its debut in […]

Read More
aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More